Patients with anti-MDA5 Abs are more likely to have clinical amyopathic DM (cADM) and are at a higher risk of ILD, particularly rapidly progressive ILD (RP-ILD) and ulcered skin lesions. This evidence concerns the gene IFIH1 and retinitis pigmentosa 1.